December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MDxHealth SA - Ordinary Shares (NQ:MDXH)

0.2072 -0.3928 (-65.47%)
Delayed Quote Updated: 2:11 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about MDxHealth SA - Ordinary Shares

< Previous 1 2 Next >
News headline image
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
From mdxhealth
Via GlobeNewswire
News headline image
Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
VivoSim Labs (NASDAQ: VIVS) Emerges in Drug Toxicity Market as Revenue Growth Guidance Tops 500% – Plus More In Focus
Via AB Newswire
Topics Animal Testing Artificial Intelligence
News headline image
Kartoon Studios (NYSE: TOON) Enters Next Growth Phase; Reports Q2 Revenue of $5.82M, EPS of $0.38 and $40.5M Cash Position – Plus More in Focus
Via AB Newswire
Topics Intellectual Property
News headline image
Mdxhealth Reports Second Quarter 2026 Financial Results
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Reports Q1-2026 Results
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth to Release First Quarter 2026 Financial Results on May 13
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth Reports Q1-2025 Results
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth to Release First Quarter 2025 Financial Results on May 14
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth to Participate in Piper Sandler Healthcare Conference
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth Announces Pricing of Offering of Ordinary Shares
From mdxhealth
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.